Omega-3 fatty acids and PPAR γ in cancer

PPAR Research

Volumn , Issue , 2008, Pages

  Edwards, Iris J ^a   O'Flaherty, Joseph T ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ESTROGEN; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; ORAL CONTRACEPTIVE AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEOGLYCAN; STEARIDONIC ACID; SYNDECAN 1; TETRACOSAHEXAENOIC ACID; TETRACOSAPENTAENOIC ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CELL DEATH; CELL PROLIFERATION; CELL SURFACE; COLON CANCER; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG METABOLISM; GENE ACTIVATION; GENE TARGETING; HUMAN; IN VITRO STUDY; NEOPLASM; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; UPREGULATION;

EID: 53149131328     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2008/358052     Document Type: Review

References (168)

1. Kersten S., Desvergne B., Wahli W., Roles of PPARS in health and disease Nature 2000 405 6785 421 424
2. Lee C.-H., Olson P., Evans R. M., Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors Endocrinology 2003 144 6 2201 2207
3. Feige J. N., Gelman L., Michalik L., Desvergne B., Wahli W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions Progress in Lipid Research 2006 45 2 120 159
4. Lazennec G., Canaple L., Saugy D., Wahli W., Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators Molecular Endocrinology 2000 14 12 1962 1975
5. Molnár F., Matilainen M., Carlberg C., Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators The Journal of Biological Chemistry 2005 280 28 26543 26556
6. Michalik L., Zoete V., Krey G., Combined simulation and mutagenesis analyses reveal the involvement of key residues for peroxisome proliferator-activated receptor α helix 12 dynamic behavior The Journal of Biological Chemistry 2007 282 13 9666 9677
7. Zoete V., Grosdidier A., Michielin O., Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators Biochimica et Biophysica Acta 2007 1771 8 915 925
8. Xu H. E., Lambert M. H., Montana V. G., Molecular recognition of fatty acids by peroxisome proliferator-activated receptors Molecular Cell 1999 3 3 397 403
9. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M., 15-deoxy- Δ 12, 14 -prostaglandin J 2 is a ligand for the adipocyte determination factor PPAR γ Cell 1995 83 5 803 812
10. Kliewer S. A., Sundseth S. S., Jones S. A., Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4318 4323
11. Forman B. M., Chen J., Evans R. M., Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4312 4317
12. Sertznig P., Seifert M., Tilgen W., Reichrath J., Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer Journal of Cellular Physiology 2007 212 1 1 12
13. Michalik L., Desvergne B., Wahli W., Peroxisome-proliferator-activated receptors and cancers: complex stories Nature Reviews Cancer 2004 4 1 61 70
14. Xu L., Han C., Wu T., A novel positive feedback loop between peroxisome proliferator-activated receptor- δ and prostaglandin E 2 signaling pathways for human cholangiocarcinoma cell growth The Journal of Biological Chemistry 2006 281 45 33982 33996
15. Michalik L., Auwerx J., Berger J. P., International union of pharmacology. LXI. Peroxisome proliferator-activated receptors Pharmacological Reviews 2006 58 4 726 741
16. Krishnan A., Nair S. A., Pillai M. R., Biology of PPAR γ in cancer: a critical review on existing lacunae Current Molecular Medicine 2007 7 6 532 540
17. Han S., Roman J., Peroxisome proliferator-activated receptor γ: a novel target for cancer therapeutics? Anti-Cancer Drugs 2007 18 3 237 244
18. Wang T., Xu J., Yu X., Yang R., Han Z. C., Peroxisome proliferator-activated receptor γ in malignant diseases Critical Reviews in Oncology/Hematology 2006 58 1 1 14
19. Sporn M. B., Suh N., Mangelsdorf D. J., Prospects for prevention and treatment of cancer with selective PPAR γ modulators (SPARMs) Trends in Molecular Medicine 2001 7 9 395 400
20. Olefsky J. M., Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists The Journal of Clinical Investigation 2000 106 4 467 472
21. Siddiqui R. A., Shaikh S. R., Sech L. A., Yount H. R., Stillwell W., Zaloga G. P., Omega 3-fatty acids: health benefits and cellular mechanisms of action Mini Reviews in Medicinal Chemistry 2004 4 8 859 871
22. Colomer R., Moreno-Nogueira J. M., García-Luna P. P., n -3 fatty acids, cancer and cachexia: a systematic review of the literature British Journal of Nutrition 2007 97 5 823 831
23. Sprecher H., Metabolism of highly unsaturated n -3 and n -6 fatty acids Biochimica et Biophysica Acta 2000 1486 2-3 219 231
24. Sprecher H., The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids Prostaglandins Leukotrienes and Essential Fatty Acids 2002 67 2-3 79 83
25. Williams C. M., Burdge G., Long-chain n -3 PUFA: plant v. marine sources Proceedings of the Nutrition Society 2006 65 1 42 50
26. Emken E. A., Adlof R. O., Gulley R. M., Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males Biochimica et Biophysica Acta 1994 1213 3 277 288
27. Burdge G. C., Wootton S. A., Conversion of α -linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women British Journal of Nutrition 2002 88 4 411 420
28. Pawlosky R. J., Hibbeln J. R., Novotny J. A., Salem N. Jr., Physiological compartmental analysis of α -linolenic acid metabolism in adult humans Journal of Lipid Research 2001 42 8 1257 1265
29. Pawlosky R. J., Hibbeln J. R., Lin Y., Effects of beef- and fish-based diets on the kinetics of n-3 fatty acid metabolism in human subjects The American Journal of Clinical Nutrition 2003 77 3 565 572
30. Giltay E. J., Gooren L. J. G., Toorians A. W. F. T., Katan M. B., Zock P. L., Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects The American Journal of Clinical Nutrition 2004 80 5 1167 1174
31. Arterburn L. M., Hall E. B., Oken H., Distribution, interconversion, and dose response of n-3 fatty acids in humans The American Journal of Clinical Nutrition 2006 83 6 1467S 1476S
32. Park Y., Harris W. S., Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance Journal of Lipid Research 2003 44 3 455 463
33. Payan D. G., Wong M. Y. S., Chernov-Rogan T., Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid Journal of Clinical Immunology 1986 6 5 402 410
34. James M. J., Gibson R. A., Cleland L. G., Dietary polyunsaturated fatty acids and inflammatory mediator production The American Journal of Clinical Nutrition 2000 71 1 343S 348S
35. Gibson R. A., Neumann M. A., James M. J., Hawkes J. S., Hall C., Cleland L. G., Effect of n-3 and n-6 dietary fats on the lipoxygenase products from stimulated rat neutrophils Prostaglandins Leukotrienes and Essential Fatty Acids 1992 46 2 87 91
36. Altmann R., Hausmann M., Spöttl T., 13-oxo-ODE is an endogenous ligand for PPAR γ in human colonic epithelial cells Biochemical Pharmacology 2007 74 4 612 622
37. Earles S. M., Bronstein J. C., Winner D. L., Bull A. W., Metabolism of oxidized linoleic acid: characterization of 13-hydroxyoctadecadienoic acid dehydrogenase activity from rat colonic tissue Biochimica et Biophysica Acta 1991 1081 2 174 180
38. Hamberg M., Stereochemistry of oxygenation of linoleic acid catalyzed by prostaglandin-endoperoxide H synthase-2 Archives of Biochemistry and Biophysics 1998 349 2 376 380
39. Brash A. R., Jisaka M., Boeglin W. E., Investigation of a second 15S-lipoxygenase in humans and its expression in epithelial tissues Advances in Experimental Medicine and Biology 2000 469 83 89
40. Huang J. T., Welch J. S., Ricote M., Interleukin-4-dependent production of PPAR- γ ligands in macrophages by 12/15-lipoxygenase Nature 1999 400 6742 378 382
41. Nagy L., Tontonoz P., Alvarez J. G. A., Chen H., Evans R. M., Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR γ Cell 1998 93 2 229 240
42. Hampel J. K. A., Brownrigg L. M., Vignarajah D., Differential modulation of cell cycle, apoptosis and PPAR γ 2 gene expression by PPAR γ agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells Prostaglandins Leukotrienes and Essential Fatty Acids 2006 74 5 283 293
43. O'Flaherty J. T., Rogers L. C., Paumi C. M., 5-oxo-ETE analogs and the proliferation of cancer cells Biochimica et Biophysica Acta 2005 1736 3 228 236
44. Erlemann K.-R., Rokach J., Powell W. S., Oxidative stress stimulates the synthesis of the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid by inflammatory cells The Journal of Biological Chemistry 2004 279 39 40376 40384
45. O'Flaherty J. T., Cordes J. F., Lee S. L., Samuel M., Thomas M. J., Chemical and biological characterization of oxo-eicosatetraenoic acids Biochimica et Biophysica Acta 1994 1201 3 505 515
46. O'Flaherty J. T., Kuroki M., Nixon A. B., 5-oxo-eicosanoids and hematopoietic cytokines cooperate in stimulating neutrophil function and the mitogen-activated protein kinase pathway The Journal of Biological Chemistry 1996 271 30 17821 17828
47. Powell W. S., Gravelle F., Gravel S., Metabolism of 5(S)-hydroxy-6,8,11, 14-eicosatetraenoic acid and other 5(S)- hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes The Journal of Biological Chemistry 1992 267 27 19233 19241
48. Powell W. S., Gravelle F., Gravel S., Phorbol myristate acetate stimulates the formation of 5-oxo-6,8,11,14- eicosatetraenoic acid by human neutrophils by activating NADPH oxidase The Journal of Biological Chemistry 1994 269 41 25373 25380
49. Lee S. H., Rangiah K., Williams M. V., Wehr A. Y., DuBois R. N., Blair I. A., Cyclooxygenase-2-mediated metabolism of arachidonic acid to 15-oxo-eicosatetraenoic acid by rat intestinal epithelial cells Chemical Research in Toxicology 2007 20 11 1665 1675
50. Gulliksson M., Brunnström Å., Johannesson M., Expression of 15-lipoxygenase type-1 in human mast cells Biochimica et Biophysica Acta 2007 1771 9 1156 1165
51. Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M., A prostaglandin J 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation Cell 1995 83 5 813 819
52. Sarraf P., Mueller E., Smith W. M., Loss-of-function mutations in PPAR γ associated with human colon cancer Molecular Cell 1999 3 6 799 804
53. Itoh T., Yamamoto K., Peroxisome proliferator activated receptor γ and oxidized docosahexaenoic acids as new class of ligand Naunyn-Schmiedeberg's Archives of Pharmacology 2008 377 4-6 541 547
54. Nosjean O., Boutin J. A., Natural ligands of PPAR γ: are prostaglandin J 2 derivatives really playing the part? Cellular Signalling 2002 14 7 573 583
55. Zingarelli B., Cook J. A., Peroxisome proliferator-activated receptor- γ is a new therapeutic target in sepsis and inflammation Shock 2005 23 5 393 399
56. Scher J. U., Pillinger M. H., 15d-PG J 2: the anti-inflammatory prostaglandin? Clinical Immunology 2005 114 2 100 109
57. González-Périz A., Planagumà A., Gronert K., Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17 S -hydroxy-DHA The FASEB Journal 2006 20 14 2537 2539
58. Shiraki T., Kamiya N., Shiki S., Kodama T. S., Kakizuka A., Jingami H., α, β -unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor γ The Journal of Biological Chemistry 2005 280 14 14145 14153
59. Rigas B., Sun Y., Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer British Journal of Cancer 2008 98 7 1157 1160
60. Freeman B. A., Baker P. R. S., Schopfer F. J., Woodcock S. R., Napolitano A., d'Ischia M., Nitro-fatty acid formation and signaling The Journal of Biological Chemistry 2008 283 23 15515 15519
61. Baker P. R. S., Lin Y., Schopfer F. J., Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands The Journal of Biological Chemistry 2005 280 51 42464 42475
62. Schopfer F. J., Lin Y., Baker P. R. S., Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor γ ligand Proceedings of the National Academy of Sciences of the United States of America 2005 102 7 2340 2345
63. O'Sullivan S. E., Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors British Journal of Pharmacology 2007 152 5 576 582
64. Lenman A., Fowler C. J., Interaction of ligands for the peroxisome proliferator-activated receptor γ with the endocannabinoid system British Journal of Pharmacology 2007 151 8 1343 1351
65. Bouaboula M., Hilairet S., Marchand J., Fajas L., Le Fur G., Casellas P., Anandamide induced PPAR γ transcriptional activation and 3T3-L1 preadipocyte differentiation European Journal of Pharmacology 2005 517 3 174 181
66. Paumi C. M., Smitherman P. K., Townsend A. J., Morrow C. S., Glutathione S -transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor γ (PPAR γ) ligand, 15-deoxy- Δ 12, 14 -prostaglandin J 2 (15-d-PG J 2) Biochemistry 2004 43 8 2345 2352
67. Paumi C. M., Wright M., Townsend A. J., Morrow C. S., Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy- Δ 12, 14 -prostaglandin J 2 in MCF7 breast cancer cells Biochemistry 2003 42 18 5429 5437
68. Murphy R. C., Zarini S., Glutathione adducts of oxyeicosanoids Prostaglandins & Other Lipid Mediators 2002 68-69 471 482
69. O'Connor R., The pharmacology of cancer resistance Anticancer Research 2007 27 3A 1267 1272
70. Olson R. E., Discovery of the lipoproteins, their role in fat transport and their significance as risk factors The Journal of Nutrition 1998 128 2 439S 443S
71. Vitols S., Peterson C., Larsson O., Holm P., Åberg B., Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo Cancer Research 1992 52 22 6244 6247
72. Lum D. F., McQuaid K. R., Gilbertson V. L., Hughes-Fulford M., Coordinate up-regulation of low-density lipoprotein receptor and cyclo- oxygenase-2 gene expression in human colorectal cells and in colorectal adenocarcinoma biopsies International Journal of Cancer 1999 83 2 162 166
73. Chen Y., Hughes-Fulford M., Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2 International Journal of Cancer 2000 91 1 41 45
74. Edwards I. J., Berquin I. M., Sun H., Differential effects of delivery of omega-3 fatty acids to human cancer cells by low-density lipoproteins versus albumin Clinical Cancer Research 2004 10 24 8275 8283
75. Sun H., Berquin I. M., Edwards I. J., Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells Cancer Research 2005 65 10 4442 4447
76. Sun H., Berquin I. M., Owens R. T., O'Flaherty J. T., Edwards I. J., Peroxisome proliferator-activated receptor γ -mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells Cancer Research 2008 68 8 2912 2919
77. Heikkinen S., Auwerx J., Argmann C. A., PPAR γ in human and mouse physiology Biochimica et Biophysica Acta 2007 1771 8 999 1013
78. Shao D., Rangwala S. M., Bailey S. T., Krakow S. L., Reginato M. J., Lazar M. A., Interdomain communication regulating ligand binding by PPAR- γ Nature 1998 396 6709 377 380
79. Camp H. S., Tafuri S. R., Leff T., c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor- γ 1 and negatively regulates its transcriptional activity Endocrinology 1999 140 1 392 397
80. Burns K. A., Vanden Heuvel J. P., Modulation of PPAR activity via phosphorylation Biochimica et Biophysica Acta 2007 1771 8 952 960
81. Papageorgiou E., Pitulis N., Msaouel P., Lembessis P., Koutsilieris M., The non-genomic crosstalk between PPAR- γ ligands and ERK1/2 in cancer cell lines Expert Opinion on Therapeutic Targets 2007 11 8 1071 1085
82. Burgermeister E., Chuderland D., Hanoch T., Meyer M., Liscovitch M., Seger R., Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor γ Molecular and Cellular Biology 2007 27 3 803 817
83. Pascual G., Fong A. L., Ogawa S., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR- γ Nature 2005 437 7059 759 763
84. Shimizu M., Yamashita D., Yamaguchi T., Hirose F., Osumi T., Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation Molecular and Cellular Biochemistry 2006 286 1-2 33 42
85. Feige J. N., Gelman L., Tudor C., Engelborghs Y., Wahli W., Desvergne B., Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand The Journal of Biological Chemistry 2005 280 18 17880 17890
86. Tudor C., Feige J. N., Pingali H., Association with coregulators is the major determinant governing peroxisome proliferator-activated receptor mobility in living cells The Journal of Biological Chemistry 2007 282 7 4417 4426
87. Powell E., Kuhn P., Xu W., Nuclear receptor cofactors in PPAR γ -mediated adipogenesis and adipocyte energy metabolism PPAR Research 2007 2007 11
88. Gao Z., He Q., Peng B., Chiao P. J., Ye J., Regulation of nuclear translocation of HDAC3 by I κ B α is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor γ function The Journal of Biological Chemistry 2006 281 7 4540 4547
89. Burgermeister E., Seger R., MAPK kinases as nucleo-cytoplasmic shuttles for PPAR γ Cell Cycle 2007 6 13 1539 1548
90. Kostadinova R., Wahli W., Michalik L., PPARs in diseases: control mechanisms of inflammation Current Medicinal Chemistry 2005 12 25 2995 3009
91. Zandbergen F., Mandard S., Escher P., The G 0 / G 1 switch gene 2 is a novel PPAR target gene Biochemical Journal 2005 392 2 313 324
92. Teunissen B. E. J., Smeets P. J. H., Willemsen P. H. M., De Windt L. J., Van der Vusse G. J., Van Bilsen M., Activation of PPAR δ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts Cardiovascular Research 2007 75 3 519 529
93. Bonofiglio D., Aquila S., Catalano S., Peroxisome proliferator-activated receptor- γ activates p53 gene promoter binding to the nuclear factor- κ B sequence in human MCF7 breast cancer cells Molecular Endocrinology 2006 20 12 3083 3092
94. Ho T.-C., Chen S.-L., Yang Y.-C., Liao C.-L., Cheng H.-C., Tsao Y.-P., PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells Cardiovascular Research 2007 76 2 213 223
95. Zand H., Rhimipour A., Bakhshayesh M., Shafiee M., Nour Mohammadi I., Salimi S., Involvement of PPAR- γ and p53 in DHA-induced apoptosis in Reh cells Molecular and Cellular Biochemistry 2007 304 1-2 71 77
96. Edwards I. J., Sun H., Hu Y., In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids The Journal of Biological Chemistry 2008 283 26 18441 18449
97. Liu J., Wang H., Zuo Y., Farmer S. R., Functional interaction between peroxisome proliferator-activated receptor γ and β -catenin Molecular and Cellular Biology 2006 26 15 5827 5837
98. Takada I., Suzawa M., Kato S., Nuclear receptors as targets for drug development: crosstalk between peroxisome proliferator-activated receptor γ and cytokines in bone marrow-derived mesenchymal stem cells Journal of Pharmacological Sciences 2005 97 2 184 189
99. Rossi A., Kapahi P., Natoli G., Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I κ B kinase Nature 2000 403 6765 103 118
100. Ackerman W. E. IV, Zhang X. L., Rovin B. H., Kniss D. A., Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NF κ B signal disruption in human WISH and amnion cells Biology of Reproduction 2005 73 3 527 535
101. Straus D. S., Glass C. K., Cyclopentenone prostaglandins: new insights on biological activities and cellular targets Medicinal Research Reviews 2001 21 3 185 210
102. Siavash H., Nikitakis N. G., Sauk J. J., Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d- PGJ 2 in oral squamous carcinoma cells British Journal of Cancer 2004 91 6 1074 1080
103. Siavash H., Nikitakis N. G., Sauk J. J., Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-deoxy- Δ 12, 14 -prostaglandin J 2 in human oral squamous carcinoma cells Cancer Letters 2004 211 1 97 103
104. Almishri W., Cossette C., Rokach J., Martin J. G., Hamid Q., Powell W. S., Effects of prostaglandin D 2, 15-deoxy- Δ 12, 14 -prostaglandin J 2, and selective DP 1 and DP 2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats Journal of Pharmacology and Experimental Therapeutics 2005 313 1 64 69
105. O'Flaherty J. T., Taylor J. S., Thomas M. J., Receptors for the 5-oxo class of eicosanoids in neutrophils The Journal of Biological Chemistry 1998 273 49 32535 32541
106. Briscoe C. P., Tadayyon M., Andrews J. L., The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids The Journal of Biological Chemistry 2003 278 13 11303 11311
107. Hirasawa A., Tsumaya K., Awaji T., Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 Nature Medicine 2005 11 1 90 94
108. Katsuma S., Hatae N., Yano T., Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1 The Journal of Biological Chemistry 2005 280 20 19507 19515
109. Hughes-Fulford M., Li C.-F., Boonyaratanakornkit J., Sayyah S., Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer Cancer Research 2006 66 3 1427 1433
110. Clay C. E., Namen A. M., Atsumi G.-I., Magnitude of peroxisome proliferator-activated receptor- γ activation is associated with important and seemingly opposite biological responses in breast cancer cells Journal of Investigative Medicine 2001 49 5 413 420
111. Gardner O. S., Dewar B. J., Graves L. M., Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling Molecular Pharmacology 2005 68 4 933 941
112. Abedin M., Lim J., Tang T. B., Park D., Demer L. L., Tintut Y., N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor- γ pathways Circulation Research 2006 98 6 727 729
113. O'Flaherty J. T., Rogers L. C., Chadwell B. A., 5(S)-hydroxy-6,8,11,14- E,Z,Z,Z -eicosatetraenoate stimulates PC3 cell signaling and growth by a receptor-dependent mechanism Cancer Research 2002 62 23 6817 6819
114. Palakurthi S. S., Aktas H., Grubissich L. M., Mortensen R. M., Halperin J. A., Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor γ and mediated by inhibition of translation initiation Cancer Research 2001 61 16 6213 6218
115. Palakurthi S. S., Flückiger R., Aktas H., Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid Cancer Research 2000 60 11 2919 2925
116. Willermain F., Dulku S., Gonzalez N. S., 15-deoxy-12,14-prostaglandin J 2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism Prostaglandins & Other Lipid Mediators 2006 80 3-4 136 143
117. Wilmer W. A., Dixon C., Lu L., Hilbelink T., Rovin B. H., A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPAR γ Biochemical and Biophysical Research Communications 2001 281 1 57 62
118. Feinstein D. L., Spagnolo A., Akar C., Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochemical Pharmacology 2005 70 2 177 188
119. Soller M., Dröse S., Brandt U., Brüne B., von Knethen A., Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells Molecular Pharmacology 2007 71 6 1535 1544
120. Chaffer C. L., Thomas D. M., Thompson E. W., Williams E. D., PPAR γ -independent induction of growth arrest and apoptosis in prostate and bladder carcinoma BMC Cancer 2006 6, article 53 1 13
121. MacLean C. H., Newberry S. J., Mojica W. A., Effects of omega-3 fatty acids on cancer risk: a systematic review Journal of the American Medical Association 2006 295 4 403 415
122. Kaizer L., Boyd N. F., Kriukov V., Tritchler D., Fish consumption and breast cancer risk: an ecological study Nutrition and Cancer 1989 12 1 61 68
123. Hursting S. D., Thornquist M., Henderson M. M., Types of dietary fat and the incidence of cancer at five sites Preventive Medicine 1990 19 3 242 253
124. Sasaki S., Horacsek M., Kesteloot H., An ecological study of the relationship between dietary fat intake and breast cancer mortality Preventive Medicine 1993 22 2 187 202
125. Terry P. D., Terry J. B., Rohan T. E., Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research The Journal of Nutrition 2004 134 12 3412S 3420S
126. Leitzmann M. F., Stampfer M. J., Michaud D. S., Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer The American Journal of Clinical Nutrition 2004 80 1 204 216
127. Caygill C. P., Charlett A., Hill M. J., Fat, fish, fish oil and cancer British Journal of Cancer 1996 74 1 159 164
128. Yeh C.-C., Hsieh L.-L., Tang R., Chang-Chieh C. R., Sung F.-C., Risk factors for colorectal cancer in Taiwan: a hospital-based case-control study Journal of the Formosan Medical Association 2003 102 5 305 312
129. Yang C.-X., Takezaki T., Hirose K., Inoue M., Huang X.-E., Tajima K., Fish consumption and colorectal cancer: a case-reference study in Japan European Journal of Cancer Prevention 2003 12 2 109 115
130. Simonsen N., van't Veer P., Strain J. J., Adipose tissue omega-3 and omega-6 fatty acid content and breast cancer in the euramic study American Journal of Epidemiology 1998 147 4 342 352
131. Mamalakis G., Kafatos A., Kalogeropoulos N., Andrikopoulos N., Daskalopulos G., Kranidis A., Prostate cancer vs hyperplasia: relationships with prostatic and adipose tissue fatty acid composition Prostaglandins Leukotrienes and Essential Fatty Acids 2002 66 5-6 467 477
132. Freeman V. L., Meydani M., Hur K., Flanigan R. C., Inverse association between prostatic polyunsaturated fatty acid and risk of locally advanced prostate carcinoma Cancer 2004 101 12 2744 2754
133. Yang Y. J., Lee S. H., Hong S. J., Chung B. C., Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasia Clinical Biochemistry 1999 32 6 405 409
134. Norrish A. E., Skeaff C. M., Arribas G. L. B., Sharpe S. J., Jackson R. T., Prostate cancer risk and consumption of fish oils: a dietary biomarker-based case-control study British Journal of Cancer 1999 81 7 1238 1242
135. Reddy B. S., Cohen L. A., McCoy G. D., Hill P., Weisburger J. H., Wynder E. L., Nutrition and its relationship to cancer Advances in Cancer Research 1980 32 237 345
136. Jurkowski J. J., Cave W. T. Jr., Dietary effects of menhaden oil on the growth and membrane lipid composition of rat mammary tumors Journal of the National Cancer Institute 1985 74 5 1145 1150
137. Braden L. M., Carroll K. K., Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats Lipids 1986 21 4 285 288
138. Rose D. P., Hatala M. A., Connolly J. M., Rayburn J., Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice Cancer Research 1993 53 18 4686 4690
139. Rose D. P., Connolly J. M., Effects of dietary omega-3 fatty acids on human breast cancer growth and metastases in nude mice Journal of the National Cancer Institute 1993 85 21 1743 1747
140. Rose D. P., Connolly J. M., Rayburn J., Coleman M., Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice Journal of the National Cancer Institute 1995 87 8 587 592
141. Cannizzo F. Jr., Broitman S. A., Postpromotional effects of dietary marine or safflower oils on large bowel or pulmonary implants of CT-26 in mice Cancer Research 1989 49 15 4289 4294
142. Iigo M., Nakagawa T., Ishikawa C., Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung British Journal of Cancer 1997 75 5 650 655
143. Boudreau M. D., Sohn K. H., Rhee S. H., Lee S. W., Hunt J. D., Hwang D. H., Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase-independent pathways Cancer Research 2001 61 4 1386 1391
144. Reddy B. S., Maruyama H., Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats Cancer Research 1986 46 7 3367 3370
145. Minoura T., Takata T., Sakaguchi M., Effect of dietary eicosapentaenoic acid on azoxymethane-induced colon carcinogenesis in rats Cancer Research 1988 48 17 4790 4794
146. Reddy B. S., Sugie S., Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats Cancer Research 1988 48 23 6642 6647
147. Takahashi M., Minamoto T., Yamashita N., Kato T., Yazawa K., Esumi H., Effect of docosahexaenoic acid on azoxymethane-induced colon carcinogenesis in rats Cancer Letters 1994 83 1-2 177 184
148. Hendrickse C. W., Keighley M. R., Neoptolemos J. P., Dietary ω -3 fats reduce proliferation and tumor yields at colorectal anastomosis in rats Gastroenterology 1995 109 2 431 439
149. Onogi N., Okuno M., Komaki C., Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats Carcinogenesis 1996 17 6 1291 1296
150. Takahashi M., Fukutake M., Isoi T., Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA) Carcinogenesis 1997 18 7 1337 1342
151. Paulsen J. E., Stamm T., Alexander J., A fish oil-derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl esters inhibits the formation and growth of aberrant crypt foci in rat colon Pharmacology & Toxicology 1998 82 1 28 33
152. Karmali R. A., Reichel P., Cohen L. A., The effects of dietary ω -3 fatty acids on the DU-145 transplantable human prostatic tumor Anticancer Research 1987 7 6 1173 1179
153. Rose D. P., Cohen L. A., Effects of dietary menhaden oil and retinyl acetate on the growth of DU 145 human prostatic adenocarcinoma cells transplanted into athymic nude mice Carcinogenesis 1988 9 4 603 605
154. Kobayashi N., Barnard R. J., Henning S. M., Effect of altering dietary ω -6/ ω -3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E 2 Clinical Cancer Research 2006 12 15 4662 4670
155. Berquin I. M., Min Y., Wu R., Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids The Journal of Clinical Investigation 2007 117 7 1866 1875
156. Rose D. P., Connolly J. M., Omega-3 fatty acids as cancer chemopreventive agents Pharmacology & Therapeutics 1999 83 3 217 244
157. Caughey G. E., Mantzioris E., Gibson R. A., Cleland L. G., James M. J., The effect on human tumor necrosis factor α and interleukin 1 β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil The American Journal of Clinical Nutrition 1996 63 1 116 122
158. Sperling R. I., Benincaso A. I., Knoell C. T., Larkin J. K., Austen K. F., Robinson D. R., Dietary ω -3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils The Journal of Clinical Investigation 1993 91 2 651 660
159. Needleman P., Raz A., Minkes M. S., Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties Proceedings of the National Academy of Sciences of the United States of America 1979 76 2 944 948
160. Mueller E., Sarraf P., Tontonoz P., Terminal differentiation of human breast cancer through PPAR γ Molecular Cell 1998 1 3 465 470
161. Mueller E., Smith M., Sarraf P., Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer Proceedings of the National Academy of Sciences of the United States of America 2000 97 20 10990 10995
162. Elstner E., Müller C., Koshizuka K., Ligands for peroxisome proliferator-activated receptory and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice Proceedings of the National Academy of Sciences of the United States of America 1998 95 15 8806 8811
163. Elstner E., Williamson E. A., Zang C., Novel therapeutic approach: ligands for PPAR γ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells Breast Cancer Research and Treatment 2002 74 2 155 165
164. Takashima T., Fujiwara Y., Higuchi K., PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity International Journal of Oncology 2001 19 3 465 471
165. Allred C. D., Talbert D. R., Southard R. C., Wang X., Kilgore M. W., PPAR γ 1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells The Journal of Nutrition 2008 138 2 250 256
166. Lee J. Y., Hwang D. H., Docosahexaenoic acid suppresses the activity of peroxisome proliferator-activated receptors in a colon tumor cell line Biochemical and Biophysical Research Communications 2002 298 5 667 674
167. Trombetta A., Maggiora M., Martinasso G., Cotogni P., Canuto R. A., Muzio G., Arachidonic and docosahexaenoic acids reduce the growth of A549 human lung-tumor cells increasing lipid peroxidation and PPARs Chemico-Biological Interactions 2007 165 3 239 250
168. Allred C. D., Kilgore M. W., Selective activation of PPAR γ in breast, colon, and lung cancer cell lines Molecular and Cellular Endocrinology 2005 235 1-2 21 29